Loading

Opportunities and challenges in developing a fully connected continuous manufacturing process for biologics

June 05, 2024
BioProcess Theater Session
EnzeneXTM, an innovative continuous manufacturing platform by Enzene, revolutionizes biologics manufacturing through seamless integration of upstream and downstream unit operations. Employing Alternative Tangential Flow (ATF) for upstream perfusion and a streamlined downstream purification system, allows for enhanced efficiency and high product quality. This approach has enabled Enzene to commercialize multiple MAbs and obtain high yields for intricate biologics while minimizing costs, space requirements, and capital investment.
Speakers
Himanshu Gadgil
CEO
Enzene Inc., USA
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS